A series of 3,3-disubstituted quinoxalinones was prepared and evaluated as
HIV-1 reverse transcriptase inhibitors. The N-allyl (6b and 6f), N-cyclopro
pylmethyl (6a, 6g, 6h, and 6k) and N-carboalkoxy (6m 6y) substituted compou
nds displayed activity comparable or better than Efavirenz and GW420867X. (
C) 2000 Dupont Pharmaceuticals Company. Published by Elsevier Science Ltd.
All rights reserved.